Académique Documents
Professionnel Documents
Culture Documents
Ophthalmology
Conjunctivitis
Bilateral
Unilateral
Watery discharge
Easily transmissible
Poorly transmissible
Normal vision
Normal vision
Itchy
Not itchy
Preauricular adenopathy
No adenopathy
No specific therapy
Topical antibiotics
.... T IP
The "must know" subjects in ophthalmology are:
497
Presentation
Itchy eyes,
discharge
Autoimmune
diseases
Pain
Trauma
Eye findings
Normal pupils
Photophobia
Clinical diagnosis
Slit lamp
examination
Tonometry
Fluorescein stain
Acetazolamide,
mannitol,
pilocarpine, laser
trabeculoplasty
No specific therapy;
patch not clearly
beneficial
Glaucoma
Chronic Glaucoma
Chronic glaucoma is most often asymptomatic on presentation and is diagnosed by routine screening. Confirmation is with tonometry indicating
extremely elevated intraocular pressure. Treat with medications to decrease the
production of aqueous humor or to increase its drainage.
Prostaglandin analogues: latanoprost, travoprost, bimatoprost
Topical beta blockers: timolol, carteolol, metipranolol, betaxolol, or
levobunolol
Topical carbonic anhydrase inhibitors: dorzolamide, brinzolamide
Alpha-2 agonists: apraclonidine
Pilocarpine
Laser trabeculoplasty: performed if medical therapy is inadequate
Acute Angle-Closure Glaucoma
Look for the sudden onset of an extremely painful, red eye that is hard to
palpation. Walking into a dark room can precipitate pain because of pupilary
dilation. The cornea is described as "steamy" and the pupil does not react to
light because it is stuck. The cup-to-disc ratio is greater than the normal 0.3.
The diagnosis is confirmed with tonometry. Treat with:
Intravenous acetazolamide
Intravenous mannitol to act as an osmotic draw of fluid out of the eye
Pilocarpine, beta blockers, and apraclonidine to constrict the pupil and
enhance drainage
Laser iridotomy
498
Ophthalmology
Herpes Keratitis
Keratitis is an infection of the cornea. The eye may be very red, swollen, and
painful, but do not use steroids. Fluorescein staining of the eye helps confirm
the dendritic pattern seen on examination. Steroids markedly increase the
production of the virus.
Treat with oral acyclovir, famciclovir, or valacyclovir. Topical antiherpetic
treatment is trifluridine and idoxuridine.
Cataracts
There is no medical therapy for cataracts. Surgically remove the lens and
replace with a new intraocular lens. The new lens may automatically have a
bifocal capability. Early cataracts are diagnosed with an ophthalmoscope or
slit lamp exam. Advanced cataracts are visible on examination.
Diabetic Retinopathy
Annual screening exams should detect retinopathy before serious visual loss
has occurred. Nonproliferative or "background" retinopathy is managed by
controlling glucose level. The most accurate test is fluorescein angiography.
Proliferative retinopathy is treated with laser photocoagulation. Vascular
endothelial growth factor inhibitors (VEGF) are injected in some patients to
control neovascularization.
Vitrectomy may be necessary to remove a vitreal hemorrhage obstructing
vision.
499
Figure 19. 2: Retinal artery occlusion presents with sudden loss of vision
and a pale retina and dark macula. Source: Conrad Fischer, MD.
500
Ophthalmology
Retinal Detachment
Risks include trauma to the eye, extreme myopia that changes the shape of the
eye, and diabetic retinopathy. Anything that pulls on the retina can detach it.
Detachment presents with the sudden onset of painless, unilateral loss of
vision that is described as "a curtain coming down."
Reattachment is attempted with a number of mechanical methods such as
surgery, laser, cryotherapy, and the injection of an expansile gas that pushes
the retina back up against the globe of the eye.
Figure 19.4: Sudden, painless loss of vision "like a curtain coming down."
Source: Conrad Fischer, MD.
Macular Degeneration
Macular degeneration is now the most common cause of blindness in older
persons in the United States. The cause is unknown. There is an atrophic (dry)
type and a neovascular (wet) type.
Visual loss in macular degeneration:
Far more common in older patients
Atrophic macular
degeneration has no
proven effective therapy.
501
The best initial therapy for neovascular disease is a VEGF inhibitor such as
ranibizumab, bevacizumab, or aflibercept. They are injected directly into the
vitreous chamber every 4 to 8 weeks. Over 90% of patients will experience a
halt of progression, and one-third of patients will have improvement in vision.
502